Table 5.

Gut bacteria on species level with the highest relative L-cysteine consumption in human samples. The second column indicates the maximal predicted L-cysteine consumption of each strain during optimal growth, the third column the average abundance in the FoCus cohort and the fourth column the abundance-weighted cystein consumption. The fifth column shows the relative L-cysteine consumption as a sum of 1 regarding microbiome abundance in the FoCus cohort

Species (strain designation in the AGORA collection)	Maximal L-cysteine consumption (mmol/gDW/h)	Average relative abundance	Abundance-weighted cystein consumption	Relative L-cysteine consumption
Dialister invisus DSM 15470	40.8	0.078	3.20	13.72%
Enterobacter cancerogenus ATCC 35316	97.7	0.027	2.68	11.53%
Escherichia coli K12 MG1655	47.1	0.052	2.47	10.59%
Prevotella copri CB7 DSM 18205	38.9	0.058	2.27	9.77%
Parasutterella excrementihominis YIT 11859	81.9	0.026	2.12	9.10%
Sutterella wadsworthensis 3145B	96.3	0.008	0.81	3.48%
Roseburia hominis A2 183	89.4	0.008	0.70	3.02%
Hafnia alvei BIDMC 31	98.1	0.007	0.70	3.01%
Bilophila wadsworthia 316	96.3	0.005	0.51	2.17%
Acidaminococcus intestini RyC MR95	88.2	0.004	0.39	1.68%